Effect of estrogen, progesterone, LH, and FSH on oxidant and antioxidant parameters in rat uterine tissue

International Journal of Fertility and Sterility

Volumn 3, Issue 3, 2009, Pages 119-128

  Borekci, Bunyamin ^a   Ingec, Metin ^a   Kumtepe, Yakup ^a   Karaca, Mehmet ^b   Koc, Feride ^c   Salman, Suleyman ^d   Gulaboglu, Mine ^c   Suleyman, Halis ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b KAFKAS UNIVERSITY   (Turkey)

^c ATATÜRK UNIVERSITY   (Turkey)

^d MINISTRY OF HEALTH   (Turkey)

Author keywords

Cyclooxygenase 1; Oxidant antioxidant parameters; Rat; Sex hormones; Uterine

Indexed keywords

CYCLOOXYGENASE 1; ESTROGEN; FOLLITROPIN; GLUTATHIONE; LUTEINIZING HORMONE; MIFEPRISTONE; NITRIC OXIDE; OXIDIZING AGENT; PROGESTERONE; YOHIMBINE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HORMONE RESPONSE; LOW DRUG DOSE; NONHUMAN; OXIDATIVE STRESS; RAT; SINGLE DRUG DOSE; TISSUE; TREATMENT DURATION; UTERUS;

EID: 73249141179     PISSN: 2008076X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Lund KJ. Menopause and the menopausal transition. Med Clin North Am. 2008; 92(5): 1253-1271.
2. Bhavnani BR, Strickler RC. Menopausal hormone therapy. J Obstet Gynaecol Can. 2005; 27(2): 137-162.
3. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004; 291(14): 1701-1712.
4. Rossouw JE, Cushman M, Greenland P, Lloyd-Jones DM, Bray P, Kooperberg C, et al. Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy. Arch Intern Med. 2008; 168(20): 2245-2253.
5. Hosie M, Adamson M, Penny C. Actin binding protein expression is altered in uterine luminal epithelium by clomiphene citrate, a synthetic estrogen receptor modulator. Theriogenology. 2008; 69(6): 700-713.
6. th Edition. Norwalk: Prentice Hall. 1993; 81-246.
7. Sokol RJ, Brindley BA. Practial diagnosis and management of abnormal labor. In: Scott JR DP, Hmmand CB, Spellacy WN (editors). Danforth's Obstetrics and Gynaecology. Philadelphia: S.B. Lippincott Company; 1990; 585-638.
8. Hosie MJ, Murphy CR. Clomiphene citrate alters surface ultrastructure of uterine luminal epithelial cells. Acta Anat (Basel). 1992; 145(2): 175-178.
9. Borekci B, Cadirci E, Albayrak A, Suleyman H, Halici Z, Kadanali S. Effects of progesterone on FSH-stimulated indomethacin ulcers in rats. Fertil Steril. 2008; 90(5): 1899-1903.
10. Borekci B, Kumtepe Y, Karaca M, Halici Z, Cadirci E, Albayrak F, et al. Role of α-2 adrenergic receptors in antiulcer effect mechanism of estrogen and LH on rats. Gynecol Endocrinol. 2009; 25(4): 264-268.
11. Fulop K, Zadori Z, Ronai AZ, Gyires K. Characterisation of alpha2-adrenoceptor subtypes involved in gastric emptying, gastric motility and gastric mucosal defence. Eur J Pharmacol. 2005; 528(1-3): 150-157.
12. Gyires K, Mullner K, Furst S, Ronai AZ. Alpha-2 adrenergic and opioid receptor-mediated gastroprotection. J Physiol Paris. 2000; 94(2): 117-121.
13. Jurgens CW, Hammad HM, Lichter JA, Boese SJ, Nelson BW, Goldenstein BL, et al. Alpha2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 region. Mol Pharmacol. 2007; 71(6): 1572-1581.
14. Le AD, Harding S, Juzytsch W, Funk D, Shaham Y. Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berl). 2005; 179(2): 366-373.
15. Cameron ST, Critchley HO, Buckley CH, Kelly RW, Baird DT. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation. Fertil Steril. 1997; 67(6): 1046-1053.
16. Sajal G, Neena M, Dipika S, Anjali C, Agarwal A. Oxidative stress and its role in female infertility and assisted reproductive. IJFS. 2009; 2(4): 147-169.
17. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968; 25(1): 192-205.
18. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem. 1995; 41(6 Pt 1): 904-907.
19. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem. 1995; 41(6 Pt 1): 892-896.
20. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982; 78(3): 206-209.
21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2): 351-358.
22. Bradford MM. Rapid and Sensitive Method for Quantitation of Microgram Quantities of Protein Utilizing Principle of Protein-Dye Binding. Anal Biochem. 1976; 72(1-2): 248-254.
23. Munoz-Castaneda JR, Muntane J, Herencia C, Munoz MC, Bujalance I, Montilla P, et al. Ovariectomy exacerbates oxidative stress and cardiopathy induced by adriamycin. Gynecol Endocrinol. 2006; 22(2): 74-79.
24. Ha BJ, Lee SH, Kim HJ, Lee JY. The role of Salicornia herbacea in ovariectomy-induced oxidative stress. Biol Pharm Bull. 2006; 29(7): 1305-1309.
25. Macnee W, Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 160(5 Pt 2): S58-65.
26. Khan NS, Malhotra S. Effect of hormone replacement therapy on cardiovascular disease: current opinion. Expert Opin Pharmacother. 2003; 4(5): 667-674.
27. Grimes DA, Lobo RA. Perspectives on the Women's Health Initiative trial of hormone replacement therapy. Obstet Gynecol. 2002; 100(6): 1344-1353.
28. Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation. 1995; 92(1): 5-8.
29. Guiochon-Mantel A. Regulation of the differentiation and proliferation of smooth muscle cells by the sex hormones. Rev Mal Respir. 2000; 17(2 Pt 2): 604-608.
30. Green PS, Gordon K, Simpkins JW. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol. 1997; 63(4-6): 229-235.
31. Oztekin E, Tiftik AM, Baltaci AK, Mogulkoc R. Lipid peroxidation in liver tissue of ovariectomized and pinealectomized rats: effect of estradiol and progesterone supplementation. Cell Biochem Funct. 2007; 25(4): 401-405.
32. Munoz-Castaneda JR, Montilla P, Munoz MC, Bujalance I, Muntane J, Tunez I. Effect of 17-beta-estradiol administration during adriamycin-induced cardiomyopathy in ovariectomized rat. Eur J Pharmacol. 2005; 523(1-3): 86-92.
33. Kim YD, Farhat MY, Myers AK, Kouretas P, DeGroot KW, Pacquing A, et al. 17-beta estradiol regulation of myocardial glutathione and its role in protection against myocardial stunning in dogs. J Cardiovasc Pharm. 1998; 32(3): 457-465.
34. Kumtepe Y, Borekci B, Karaca M, Salman S, Alp HH, Suleyman H. Effect of acute and chronic administration of progesterone, estrogen, FSH and LH on oxidant and antioxidant parameters in rat gastric tissue. Chem Biol Interact. 2009; 182(1): 1-6.
35. Knoblauch R, Garabedian MJ. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction. Mol Cell Biol. 1999; 19(5): 3748-3759.
36. Moggs JG, Orphanides G. Estrogen receptors: orchestrators of pleiotropic cellular responses. Embo Rep. 2001; 2(9): 775-781.
37. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol. 1997; 51(4): 535-541.
38. Speir E, Yu ZX, Takeda K, Ferrans VJ, Cannon RO, 3rd. Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells. Circulation. 2000; 102(24): 2990-2996.
39. Ajaikumar KB, Asheef M, Babu BH, Padikkala J. The inhibition of gastric mucosal injury by Punicagranatum L. (pomegranate) methanolic extract. J Ethnopharmacol. 2005; 96(1-2): 171-176.
40. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997; 82(2): 291-295.
41. Cadirci E, Suleyman H, Aksoy H, Halici Z, Ozgen U, Koc A, et al. Effects of Onosma armeniacum root extract on ethanol-induced oxidative stress in stomach tissue of rats. Chem Biol Interact. 2007; 170(1): 40-48.
42. Martin MJ, Jimenez MD, Motilva V. New issues about nitric oxide and its effects on the gastrointestinal tract. Curr Pharm Des. 2001; 7(10): 881-908.
43. Hogg N, Kalyanaraman B. Nitric oxide and lipid peroxidation. Biochim Biophys Acta. 1999; 1411(2-3): 378-384.
44. Bauer JA, Booth BP, Fung HL. Nitric oxide donors: biochemical pharmacology and therapeutics. Adv Pharmacol. 1995; 34: 361-381.
45. Talas DU, Nayci A, Polat G, Atis S, Comelekoglu U, Bagdatoglu OT, et al. The effects of dexamethasone on lipid peroxidation and nitric oxide levels on the healing of tracheal anastomoses: an experimental study in rats. Pharmacol Res. 2002; 46(3): 265-271.
46. Sanchez S, Martin MJ, Ortiz P, Motilva V, Alarcon de la Lastra C. Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa: comparison with acetaminophen and diclofenac. Dig Dis Sci. 2002; 47(6): 1389-1398.
47. van Ryn J, Trummlitz G, Pairet M. COX-2 selectivity and inflammatory processes. Curr Med Chem. 2000; 7(11): 1145-1161.
48. Burian M, Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther. 2005; 107(2): 139-154.